Marcia Belvin Cytom X Therapeutics, Inc. (CTMX) insider trading activity
Marcia Belvin is SVP, Chief Scientific Officer of CytomX Therapeutics, Inc.. Currently has a direct ownership of 248,636 shares of CTMX, which is worth approximately $156,640. The most recent transaction as insider was on Mar 18, 2025, when has been sold 19,512 shares (Common Stock) at a price of $0.6 per share, resulting in proceeds of $11,707. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
249K
41.55%
3M change
47.49%
12M change
Total Value Held
$156,640
MARCIA BELVIN Transaction History
MB
Marcia Belvin
SVP, Chief Scientific Officer
South San Francisco, CA